The Biotechnology industry is part of the Healthcare sector. It holds 1,512 US-listed stocks. Their average AI MoonshotScore is 57 out of 100. The top 3 names are EXEL, HRMY, INCY.
Healthcare
1,512 Stocks
Biotechnology Stocks
Complete list of 1,512 Biotechnology industry stocks with AI-powered MoonshotScore analysis, market-hours price data, and provider-sourced market insights. Part of the Healthcare sector.
▲
Advancing:
101
●
Avg Score:
57
■
Companies:
1,512
Biotechnology Industry Overview
The Biotechnology industry, part of the Healthcare sector, comprises 1,512 publicly traded companies with a combined market capitalization of $1.0T.
Today's market sentiment for Biotechnology stocks is Bullish, with 101 stocks advancing and 92 declining. The average price movement across the industry is +0.18%.
The average AI MoonshotScore across Biotechnology stocks is 57/100. MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). It reads no news-sentiment or analyst data, and it is not a probability of future returns.
Total Market Cap
$1.0T
Median Market Cap
$750M
Avg MoonshotScore
57
Top MoonshotScore
98
Advancing Today
101
Total Companies
200
▲ Top Gainers Today
ANRO
How Are Biotechnology Stocks Distributed by Market Cap?
How Biotechnology companies are distributed across market capitalization tiers.
Large Cap
$10B–$200B · 22 stocks
Mid Cap
$2B–$10B · 46 stocks
Small Cap
Under $2B · 132 stocks
Frequently Asked Questions
How many stocks are in the Biotechnology industry?
There are currently 1,512 publicly traded companies classified under the Biotechnology industry within the Healthcare sector. The tracked companies carry a combined market capitalization of $1.0T, with 101 advancing and 92 declining in today's trading.
Which Biotechnology stocks rank highest by MoonshotScore?
Based on our AI MoonshotScore analysis, the top-rated Biotechnology stocks are EXEL, HRMY, INCY. Always conduct your own research before investing.
What are the largest Biotechnology companies by market cap?
The largest Biotechnology companies by market capitalization are NVO ($166.70B), VRTX ($127.79B), REGN ($74.89B). Across the tracked list, the median market capitalization is $750M — a gauge of how top-heavy the industry is beyond its largest names.
What is the average MoonshotScore for Biotechnology stocks?
The current average MoonshotScore for the Biotechnology industry is 57/100. The strongest current score in the industry is 98/100. MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). It reads no news-sentiment or analyst data, and it is not a probability of future returns.
How does the Biotechnology industry perform compared to the overall market?
Biotechnology stocks are tracked against broader market benchmarks. You can compare sector and industry performance on our Market Sectors dashboard.
Our Analysis Methodology
Stock Expert AI rates eligible U.S.-listed companies with the MoonshotScore, a proprietary 0–100 composite rating. V2 is the only current model: eligible companies are scored against their sector peers across five pillars — business quality, financial safety, valuation, growth durability, and momentum. MoonshotScore V2 covers eligible common stocks and ADRs on NASDAQ, NYSE and AMEX. OTC listings are outside the scheduled universe; funds, ETFs, warrants, units, SPACs, preferreds, and notes carry no MoonshotScore.
MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). It reads no news-sentiment or analyst data, and it is not a probability of future returns.
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Each price is the last quote we recorded, shown with the trading session it belongs to. Pages are served from a cache, so the copy you are reading can lag that quote. Each quote is a provider snapshot, not an exchange feed.
Sector names are the familiar eleven, but the classification itself is our data provider's, not GICS, and departs from it in places — mortgage REITs, education and packaging are filed the way GICS files them; the rest follow the provider. Companies are assigned to one sector and to one of 50+ industries by their primary revenue source.
Explore More
Healthcare Sector →
View all industries and stocks in the Healthcare sector.
All Industries →
Browse all industries across every sector.
All Sectors →
Compare all 11 sectors by size, performance, and AI scores.
Stock Screener →
Filter Biotechnology stocks by market cap, MoonshotScore, and more.
Discover →
Search for any stock by ticker, company name, or keyword.
Data is provided for informational purposes only and should not be considered investment advice. Stock prices, market capitalizations, and MoonshotScores are updated throughout the trading day. Past performance does not guarantee future results. Always consult with a qualified financial advisor before making investment decisions.
Which stocks are in the Biotechnology industry? (Page 1 of 8)
1–200 of 1,512 shown| Stock | Price | Change | Volume | Market Cap | MoonshotScore | Sector |
|---|---|---|---|---|---|---|
|
EXEL
Exelixis, Inc.
|
$58.85 | +0.79% | 2.6M | $14.79B | 98 | Healthcare |
|
HRMY
Harmony Biosciences Holdings, Inc.
|
$39.92 | +0.71% | 898K | $2.31B | 98 | Healthcare |
|
INCY
Incyte Corporation
|
$113.81 | -1.29% | 704.3K | $23.07B | 98 | Healthcare |
|
KRYS
Krystal Biotech, Inc.
|
$334.85 | +3.90% | 337.0K | $9.87B | 98 | Healthcare |
|
ARGX
argenx SE
|
$912.87 | -0.69% | 322.1K | $56.77B | 97 | Healthcare |
|
AUPH
Aurinia Pharmaceuticals Inc.
|
$15.72 | -0.69% | 802K | $2.02B | 97 | Healthcare |
|
ETON
Eton Pharmaceuticals, Inc.
|
$55.62 | +0.47% | 392K | $1.52B | 97 | Healthcare |
|
HALO
Halozyme Therapeutics, Inc.
|
$108.53 | -1.22% | 575K | $12.87B | 97 | Healthcare |
|
UTHR
United Therapeutics Corporation
|
$536.40 | -0.98% | 814.1K | $22.77B | 97 | Healthcare |
|
VRTX
Vertex Pharmaceuticals Incorporated
|
$503.50 | -0.24% | 914.8K | $127.79B | 97 | Healthcare |
|
LGND
Ligand Pharmaceuticals Incorporated
|
$306.77 | +1.26% | 163.8K | $6.15B | 96 | Healthcare |
|
VCYT
Veracyte, Inc.
|
$47.67 | +4.06% | 1.3M | $3.80B | 96 | Healthcare |
|
INVA
Innoviva, Inc.
|
$20.64 | +0.68% | 993.2K | $1.52B | 95 | Healthcare |
|
TBPH
Theravance Biopharma, Inc.
|
$17.03 | +0.00% | 10.02M | $882.64M | 95 | Healthcare |
|
ADMA
ADMA Biologics, Inc.
|
$10.11 | +4.01% | 3.5M | $2.34B | 94 | Healthcare |
|
CRMD
CorMedix Inc.
|
$7.27 | +1.17% | 786K | $570.69M | 94 | Healthcare |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$726.94 | -1.12% | 694.7K | $74.89B | 94 | Healthcare |
|
NBIX
Neurocrine Biosciences, Inc.
|
$144.21 | +0.72% | 1.7M | $14.50B | 93 | Healthcare |
|
RIGL
Rigel Pharmaceuticals, Inc.
|
$47.79 | +1.36% | 391.3K | $884.22M | 93 | Healthcare |
|
TECH
Bio-Techne Corporation
|
$72.58 | +0.25% | 2.1M | $11.36B | 93 | Healthcare |
|
LQDA
Liquidia Corporation
|
$27.11 | -5.32% | 4.4M | $2.41B | 92 | Healthcare |
|
VCEL
Vericel Corporation
|
$41.07 | +2.29% | 648.5K | $2.10B | 92 | Healthcare |
|
CORT
Corcept Therapeutics Incorporated
|
$121.38 | +4.43% | 348K | $13.12B | 91 | Healthcare |
|
NVO
Novo Nordisk A/S
|
$37.54 | +0.59% | 18.04M | $166.70B | 91 | Healthcare |
|
ZVRA
Zevra Therapeutics, Inc.
|
$10.70 | +7.11% | 1.98M | $632.53M | 91 | Healthcare |
|
CAI
Caris Life Sciences, Inc.
|
$30.20 | +6.70% | 2.2M | $8.54B | 90 | Healthcare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$219.89 | +0.08% | 1.28M | $29.42B | 89 | Healthcare |
|
ARQT
Arcutis Biotherapeutics, Inc.
|
$25.15 | -0.04% | 2.31M | $3.15B | 88 | Healthcare |
|
ASND
Ascendis Pharma A/S
|
$228.03 | +0.07% | 783K | $14.16B | 88 | Healthcare |
|
MDXG
MiMedx Group, Inc.
|
$4.55 | -0.87% | 894.7K | $663.21M | 88 | Healthcare |
|
ABUS
Arbutus Biopharma Corporation
|
$4.67 | +4.94% | 6.18M | $922.50M | 85 | Healthcare |
|
RLYB
Rallybio Corporation
|
$16.90 | -1.05% | 5K | $89.69M | 82 | Healthcare |
|
ANAB
AnaptysBio, Inc.
|
$49.20 | +1.38% | 595.5K | $1.46B | 81 | Healthcare |
|
PHAR
Pharming Group N.V.
|
$9.73 | -0.66% | 4K | $689.02M | 77 | Healthcare |
|
ACAD
ACADIA Pharmaceuticals Inc.
|
$20.11 | +0.80% | 3.2M | $3.44B | 76 | Healthcare |
|
ORMP
Oramed Pharmaceuticals Inc.
|
$4.55 | +1.34% | 104K | $186.21M | 76 | Healthcare |
|
PTGX
Protagonist Therapeutics, Inc.
|
$141.19 | +0.81% | 341K | $9.08B | 76 | Healthcare |
|
ELVN
Enliven Therapeutics, Inc.
|
$45.47 | -3.19% | 821K | $3.25B | 73 | Healthcare |
|
RPRX
Royalty Pharma plc
|
$56.66 | -0.87% | 3.96M | $25.12B | 73 | Healthcare |
|
MBX
MBX Biosciences
|
$58.73 | +0.38% | 168.3K | $2.80B | 70 | Healthcare |
|
BLTE
Belite Bio, Inc.
|
$159.73 | +0.11% | 85.0K | $6.40B | 69 | Healthcare |
|
CLYM
Climb Bio, Inc.
|
$11.05 | +1.01% | 1.2M | $632.76M | 69 | Healthcare |
|
NAGE
Niagen Bioscience Inc
|
$2.68 | -3.94% | 864.8K | $213.45M | 69 | Healthcare |
|
LBRX
LB Pharmaceuticals Inc
|
$34.62 | -6.41% | 494K | $992.79M | 68 | Healthcare |
|
ORKA
Oruka Therapeutics, Inc.
|
$84.38 | -0.17% | 629.6K | $5.09B | 68 | Healthcare |
|
QTTB
Q32 Bio Inc.
|
$8.37 | +1.70% | 955K | $249.12M | 68 | Healthcare |
|
ANTX
AN2 Therapeutics, Inc.
|
$5.61 | -1.75% | 299.9K | $202.05M | 67 | Healthcare |
|
MGTX
MeiraGTx Holdings plc
|
$10.92 | +1.20% | 941.5K | $1.01B | 67 | Healthcare |
|
AMLX
Amylyx Pharmaceuticals, Inc.
|
$27.72 | -0.22% | 213.4K | $3.08B | 66 | Healthcare |
|
EWTX
Edgewise Therapeutics, Inc.
|
$40.30 | -2.66% | 1.6M | $4.34B | 66 | Healthcare |
|
ORIC
ORIC Pharmaceuticals, Inc.
|
$12.49 | +2.34% | 1.39M | $1.29B | 66 | Healthcare |
|
BMRN
BioMarin Pharmaceutical Inc.
|
$57.54 | +0.63% | 2.41M | $11.12B | 65 | Healthcare |
|
TGTX
TG Therapeutics, Inc.
|
$53.43 | -1.58% | 597K | $8.18B | 65 | Healthcare |
|
ALKS
Alkermes plc
|
$42.76 | +2.42% | 3M | $7.17B | 64 | Healthcare |
|
MANE
Veradermics, Incorporated
|
$118.87 | +1.81% | 536.2K | $4.97B | 64 | Healthcare |
|
TRVI
Trevi Therapeutics, Inc.
|
$13.72 | -1.37% | 1.72M | $1.95B | 64 | Healthcare |
|
SLS
SELLAS Life Sciences Group, Inc.
|
$11.63 | -0.94% | 4.51M | $2.16B | 63 | Healthcare |
|
ERAS
Erasca, Inc.
|
$14.70 | -0.14% | 90.7K | $5.10B | 62 | Healthcare |
|
SGP
SpyGlass Pharma, Inc. Common Stock
|
$25.59 | +2.69% | 133.1K | $855.56M | 62 | Healthcare |
|
ANRO
Alto Neuroscience, Inc.
|
$24.04 | +0.12% | 141.2K | $843.66M | 61 | Healthcare |
|
IMMX
Immix Biopharma, Inc.
|
$10.23 | +5.70% | 953.3K | $556.64M | 61 | Healthcare |
|
PLX
Protalix BioTherapeutics, Inc.
|
$2.71 | +0.00% | 984K | $218.35M | 61 | Healthcare |
|
CTNM
Contineum Therapeutics, Inc.
|
$12.72 | -3.05% | 508.4K | $478.54M | 60 | Healthcare |
|
DSGN
Design Therapeutics, Inc.
|
$12.24 | -1.44% | 202.1K | $764.57M | 60 | Healthcare |
|
GMAB
Genmab A/S
|
$38.48 | +10.73% | 12.40M | $23.62B | 60 | Healthcare |
|
DRTS
Alpha Tau Medical Ltd.
|
$14.89 | +0.81% | 341.1K | $1.34B | 59 | Healthcare |
|
RLMD
Relmada Therapeutics, Inc.
|
$3.48 | -3.33% | 1.28M | $365.02M | 59 | Healthcare |
|
BNTC
Benitec Biopharma Inc.
|
$9.23 | +2.78% | 584.2K | $317.09M | 58 | Healthcare |
|
KOD
Kodiak Sciences Inc.
|
$93.81 | -0.68% | 3.23M | $5.87B | 58 | Healthcare |
|
NBP
NovaBridge Biosciences
|
$1.36 | +0.37% | 185.0K | $156.76M | 58 | Healthcare |
|
PHVS
Pharvaris N.V.
|
$30.49 | -2.24% | 816.1K | $2.13B | 58 | Healthcare |
|
PRAX
Praxis Precision Medicines, Inc.
|
$283.87 | -3.94% | 209.4K | $7.91B | 58 | Healthcare |
|
SGMT
Sagimet Biosciences Inc.
|
$9.03 | -1.20% | 1.53M | $294.21M | 58 | Healthcare |
|
AVBP
ArriVent BioPharma, Inc.
|
$12.88 | -54.73% | 10.03M | $600.12M | 57 | Healthcare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.74 | -1.47% | 823.7K | $903.13M | 57 | Healthcare |
|
EPRX
Eupraxia Pharmaceuticals Inc.
|
$7.75 | +6.98% | 1.8M | $259.30M | 57 | Healthcare |
|
GHRS
GH Research PLC
|
$22.50 | -1.94% | 78.3K | $1.54B | 57 | Healthcare |
|
JBIO
Jade Biosciences, Inc.
|
$13.65 | -2.97% | 148.1K | $830.85M | 57 | Healthcare |
|
RVMD
Revolution Medicines, Inc.
|
$207.68 | +0.50% | 1.42M | $44.15B | 57 | Healthcare |
|
HELP
Cybin Inc.
|
$11.42 | -2.39% | 1.32M | $707.86M | 56 | Healthcare |
|
IFRX
InflaRx N.V.
|
$1.68 | -2.33% | 701.0K | $247.45M | 56 | Healthcare |
|
IKT
Inhibikase Therapeutics, Inc.
|
$2.00 | +0.00% | 407.3K | $264.07M | 56 | Healthcare |
|
NVCT
Nuvectis Pharma, Inc.
|
$21.39 | -2.42% | 185.1K | $567.61M | 56 | Healthcare |
|
PCVX
Vaxcyte, Inc.
|
$73.82 | +30.70% | 14.84M | $10.66B | 56 | Healthcare |
|
PVLA
Palvella Therapeutics, Inc.
|
$132.16 | -0.23% | 140.6K | $1.90B | 56 | Healthcare |
|
TYRA
Tyra Biosciences, Inc.
|
$20.93 | +2.45% | 613.4K | $1.25B | 56 | Healthcare |
|
XENE
Xenon Pharmaceuticals Inc.
|
$37.57 | -1.18% | 1.7M | $3.63B | 56 | Healthcare |
|
ANIX
Anixa Biosciences, Inc.
|
$2.95 | +0.00% | 369.3K | $100.37M | 55 | Healthcare |
|
AURA
Aura Biosciences, Inc.
|
$6.22 | +2.13% | 590K | $643.37M | 55 | Healthcare |
|
GPCR
Structure Therapeutics Inc.
|
$27.59 | -0.29% | 1.55M | $1.59B | 55 | Healthcare |
|
IMNM
Immunome, Inc.
|
$20.55 | -2.94% | 264.4K | $1.96B | 55 | Healthcare |
|
INDP
Indaptus Therapeutics, Inc.
|
$2.51 | +5.46% | 359.5K | $284.24M | 55 | Healthcare |
|
OKUR
OnKure Therapeutics, Inc.
|
$2.56 | -0.04% | 202.0K | $103.63M | 55 | Healthcare |
|
TECX
Tectonic Therapeutic, Inc.
|
$23.11 | +2.53% | 312.6K | $436.07M | 55 | Healthcare |
|
TELO
Telomir Pharmaceuticals, Inc.
|
$1.21 | +2.54% | 134.4K | $83.22M | 55 | Healthcare |
|
VOR
Vor Biopharma, Inc.
|
$18.58 | -0.59% | 648.5K | $1.01B | 55 | Healthcare |
|
BCAX
Bicara Therapeutics Inc.
|
$17.29 | -1.93% | 640.7K | $1.14B | 54 | Healthcare |
|
CADL
Candel Therapeutics, Inc.
|
$10.23 | +0.49% | 979.4K | $749.55M | 54 | Healthcare |
|
DFTX
DFTX
|
$36.23 | -3.13% | 2.60M | $4.81B | 54 | Healthcare |
|
DMAC
DiaMedica Therapeutics Inc.
|
$8.42 | +2.31% | 231.4K | $453.70M | 54 | Healthcare |
|
GRCE
Grace Therapeutics, Inc.
|
$2.06 | -0.47% | 67.3K | $33.53M | 54 | Healthcare |
|
PLYX
Polaryx Therapeutics, Inc. Common Stock
|
$2.07 | -0.48% | 40.1K | $103.18M | 54 | Healthcare |
|
COGT
Cogent Biosciences, Inc.
|
$30.87 | -0.48% | 1.79M | $5.27B | 53 | Healthcare |
|
IRON
Disc Medicine, Inc.
|
$63.33 | -1.83% | 456.3K | $2.43B | 53 | Healthcare |
|
MLYS
Mineralys Therapeutics, Inc.
|
$23.01 | -1.24% | 139.8K | $2.03B | 53 | Healthcare |
|
RZLT
Rezolute, Inc.
|
$4.18 | +4.36% | 1.63M | $402.98M | 53 | Healthcare |
|
SVRA
Savara Inc.
|
$4.78 | -0.62% | 2.9M | $979.55M | 53 | Healthcare |
|
ABVX
Abivax S.A.
|
$91.73 | -1.24% | 840.2K | $6.74B | 52 | Healthcare |
|
AVIR
Atea Pharmaceuticals, Inc.
|
$5.11 | -0.39% | 150.7K | $408.94M | 52 | Healthcare |
|
BNTX
BioNTech SE
|
$98.09 | +1.23% | 953.9K | $24.64B | 52 | Healthcare |
|
ENLV
Enlivex Therapeutics Ltd.
|
$0.36 | -6.53% | 422K | $6.09M | 52 | Healthcare |
|
PLRZ
Polyrizon Ltd.
|
$9.26 | -3.64% | 16.8K | $10.37M | 52 | Healthcare |
|
SMMT
Summit Therapeutics Inc.
|
$17.27 | +3.07% | 5.25M | $13.78B | 52 | Healthcare |
|
XBIT
XBiotech Inc.
|
$2.18 | -0.46% | 32.7K | $66.46M | 52 | Healthcare |
|
ATHE
Alterity Therapeutics Limited
|
$3.15 | -8.68% | 44.7K | $53.37M | 51 | Healthcare |
|
CELC
Celcuity Inc.
|
$73.62 | +2.11% | 1.3M | $3.59B | 51 | Healthcare |
|
IMRX
Immuneering Corporation
|
$4.08 | +0.25% | 270K | $148.11M | 51 | Healthcare |
|
SABS
SAB Biotherapeutics, Inc.
|
$3.10 | +4.03% | 866.2K | $282.06M | 51 | Healthcare |
|
ARTV
Artiva Biotherapeutics, Inc.
|
$7.13 | +4.39% | 473K | $348.59M | 50 | Healthcare |
|
DRUG
Bright Minds Biosciences Inc.
|
$49.79 | -1.78% | 55.9K | $487.30M | 50 | Healthcare |
|
MNPR
Monopar Therapeutics Inc.
|
$77.20 | -1.39% | 39.1K | $517.17M | 50 | Healthcare |
|
ZURA
Zura Bio Limited
|
$3.93 | -4.38% | 2.6M | $373.34M | 50 | Healthcare |
|
AVXL
Anavex Life Sciences Corp.
|
$1.65 | -9.62% | 2M | $152.45M | 49 | Healthcare |
|
CYPH
Cypherpunk Technologies Inc.
|
$3.17 | +4.62% | 14.07M | $337.49M | 49 | Healthcare |
|
SLDB
Solid Biosciences Inc.
|
$7.06 | +3.07% | 1.37M | $695.05M | 49 | Healthcare |
|
TTRX
Turn Therapeutics Inc.
|
$12.36 | -7.28% | 111.3K | $368.18M | 49 | Healthcare |
|
FULC
Fulcrum Therapeutics, Inc.
|
$3.71 | +0.41% | 510.8K | $282.68M | 48 | Healthcare |
|
KNSA
Kiniksa Pharmaceuticals, Ltd.
|
$76.31 | +0.69% | 382.9K | $5.82B | 48 | Healthcare |
|
NSRX
Nasus Pharma Ltd.
|
$3.85 | -1.79% | 9.6K | $33.16M | 48 | Healthcare |
|
WHWK
Whitehawk Therapeutics Inc
|
$3.70 | +0.00% | 289.1K | $210.93M | 48 | Healthcare |
|
DYN
Dyne Therapeutics, Inc.
|
$15.44 | +1.58% | 4.37M | $2.88B | 47 | Healthcare |
|
EIKN
Eikon Therapeutics, Inc. Common Stock
|
$7.38 | +0.68% | 229.3K | $399.53M | 47 | Healthcare |
|
GLSI
Greenwich LifeSciences, Inc.
|
$16.91 | -0.41% | 98.7K | $248.21M | 47 | Healthcare |
|
NGNE
Neurogene Inc.
|
$26.47 | +3.20% | 211.8K | $418.29M | 47 | Healthcare |
|
TARA
Protara Therapeutics, Inc.
|
$2.63 | -2.59% | 1.4M | $147.82M | 47 | Healthcare |
|
EQ
Equillium, Inc.
|
$1.42 | -2.07% | 72.8K | $89.78M | 46 | Healthcare |
|
LXEO
Lexeo Therapeutics
|
$3.29 | -3.52% | 387.1K | $258.34M | 46 | Healthcare |
|
OLMA
Olema Pharmaceuticals, Inc.
|
$8.25 | +0.30% | 1.01M | $720.62M | 46 | Healthcare |
|
SION
Sionna Therapeutics, Inc.
|
$4.85 | -1.22% | 1.10M | $218.98M | 46 | Healthcare |
|
VERA
Vera Therapeutics, Inc.
|
$29.83 | -1.94% | 2.72M | $2.14B | 46 | Healthcare |
|
MLTX
MoonLake Immunotherapeutics
|
$11.38 | -0.26% | 1.86M | $957.23M | 45 | Healthcare |
|
PMN
PMN
|
$9.37 | -0.32% | 37.9K | $84.03M | 45 | Healthcare |
|
VKTX
Viking Therapeutics, Inc.
|
$29.25 | -2.30% | 5.29M | $3.41B | 45 | Healthcare |
|
CGEN
Compugen Ltd.
|
$2.31 | +0.00% | 198.1K | $218.42M | 44 | Healthcare |
|
FBIO
Fortress Biotech, Inc.
|
$2.09 | +2.96% | 553.4K | $69.43M | 44 | Healthcare |
|
IBO
Impact BioMedical Inc.
|
$4.92 | +1.65% | 10.3K | $42.03M | 44 | Healthcare |
|
IMA
ImageneBio Inc
|
$4.70 | +2.17% | 8.5K | $53.01M | 44 | Healthcare |
|
KTTA
Pasithea Therapeutics Corp.
|
$0.45 | -4.43% | 84.6K | $15.20M | 44 | Healthcare |
|
SRRK
Scholar Rock Holding Corporation
|
$43.40 | -7.28% | 3.35M | $5.20B | 44 | Healthcare |
|
AARD
Aardvark Therapeutics, Inc.
|
$5.22 | +4.61% | 61.3K | $114.24M | 43 | Healthcare |
|
CDT
CDT Equity Inc.
|
$0.92 | -7.30% | 337.0K | $707,297 | 43 | Healthcare |
|
CMPX
Compass Therapeutics, Inc.
|
$0.96 | +12.13% | 15.54M | $172.99M | 43 | Healthcare |
|
CURX
Curanex Pharmaceuticals Inc Common Stock
|
$4.96 | +5.08% | 87.4K | $7.03M | 43 | Healthcare |
|
MPLT
MapLight Therapeutics, Inc.
|
$9.37 | -4.58% | 168K | $397.63M | 43 | Healthcare |
|
CGTX
Cognition Therapeutics, Inc.
|
$0.94 | +1.41% | 325.7K | $83.96M | 42 | Healthcare |
|
TLX
Telix Pharmaceuticals Limited
|
$10.88 | +3.13% | 235.3K | $3.69B | 41 | Healthcare |
|
JAZZ
Jazz Pharmaceuticals plc
|
$236.04 | +0.16% | 845K | $14.83B | 40 | Healthcare |
|
SPRO
Spero Therapeutics, Inc.
|
$1.16 | -2.52% | 935.7K | $67.17M | 40 | Healthcare |
|
ARVN
Arvinas, Inc.
|
$7.46 | +0.67% | 627.4K | $481.33M | 39 | Healthcare |
|
ASMB
Assembly Biosciences, Inc.
|
$22.74 | +0.89% | 241.7K | $450.64M | 39 | Healthcare |
|
BBOT
BridgeBio Oncology Therapeutics Inc.
|
$3.60 | -7.46% | 482K | $288.39M | 39 | Healthcare |
|
CAPR
Capricor Therapeutics, Inc.
|
$7.69 | -1.19% | 560.6K | $442.12M | 38 | Healthcare |
|
FENC
Fennec Pharmaceuticals Inc.
|
$10.62 | +4.12% | 118.0K | $368.91M | 38 | Healthcare |
|
ALPS
Alps Group Inc
|
$0.40 | +1.27% | 69.4K | $66.56M | 37 | Healthcare |
|
INM
InMed Pharmaceuticals Inc.
|
$1.33 | +0.00% | 29.0K | $7.31M | 37 | Healthcare |
|
UNCY
Unicycive Therapeutics, Inc.
|
$4.22 | +0.12% | 393.4K | $112.81M | 37 | Healthcare |
|
XERS
Xeris Biopharma Holdings, Inc.
|
$10.13 | +11.56% | 4.29M | $1.75B | 37 | Healthcare |
|
ADPT
Adaptive Biotechnologies Corporation
|
$29.84 | +5.26% | 1.41M | $4.78B | 36 | Healthcare |
|
AXSM
Axsome Therapeutics, Inc.
|
$177.08 | -1.21% | 858.9K | $9.11B | 36 | Healthcare |
|
OMER
Omeros Corporation
|
$18.90 | +1.56% | 1.07M | $1.37B | 36 | Healthcare |
|
PBYI
Puma Biotechnology, Inc.
|
$9.67 | +1.68% | 298K | $492.20M | 36 | Healthcare |
|
TARS
Tarsus Pharmaceuticals, Inc.
|
$74.45 | +1.99% | 805.3K | $3.20B | 36 | Healthcare |
|
TVTX
Travere Therapeutics, Inc.
|
$57.67 | +1.30% | 2.64M | $5.36B | 36 | Healthcare |
|
VTVT
vTv Therapeutics Inc.
|
$30.73 | +0.53% | 11.4K | $80.43M | 36 | Healthcare |
|
FBIOP
Fortress Biotech, Inc.
|
$17.46 | +3.56% | 22.6K | $137.45M | 35 | Healthcare |
|
GYRE
Gyre Therapeutics, Inc.
|
$7.35 | +3.38% | 181.3K | $819.44M | 35 | Healthcare |
|
IMCR
Immunocore Holdings plc
|
$29.53 | -0.19% | 281.6K | $1.50B | 35 | Healthcare |
|
LEGN
Legend Biotech Corporation
|
$18.53 | -0.22% | 1M | $3.43B | 35 | Healthcare |
|
PTCT
PTC Therapeutics, Inc.
|
$63.65 | +0.30% | 1.04M | $5.31B | 35 | Healthcare |
|
PEPG
PepGen Inc.
|
$2.36 | +3.29% | 399K | $162.90M | 34 | Healthcare |
|
RNA
Avidity Biosciences, Inc.
|
$7.97 | +1.66% | 258.3K | $136.33M | 34 | Healthcare |
|
SEPN
Septerna, Inc.
|
$37.94 | +0.60% | 146.8K | $1.71B | 34 | Healthcare |
|
DWTX
Dogwood Therapeutics, Inc.
|
$1.52 | +4.11% | 99.6K | $51.12M | 33 | Healthcare |
|
ELOX
Eloxx Pharmaceuticals, Inc.
|
$15.41 | -0.64% | 26.1K | $52.95M | 33 | Healthcare |
|
GANX
Gain Therapeutics, Inc.
|
$1.69 | -1.17% | 345.9K | $72.09M | 33 | Healthcare |
|
INBX
Inhibrx Biosciences, Inc.
|
$94.56 | -2.51% | 206.6K | $1.39B | 33 | Healthcare |
|
INKT
MiNK Therapeutics, Inc.
|
$12.20 | -1.93% | 27.8K | $60.78M | 33 | Healthcare |
|
MRVI
Maravai LifeSciences Holdings, Inc.
|
$8.52 | +7.85% | 2.63M | $2.35B | 33 | Healthcare |
|
NNVC
NanoViricides, Inc.
|
$1.41 | +10.16% | 318.9K | $35.81M | 33 | Healthcare |
|
PBM
Psyence Biomedical Ltd.
|
$5.08 | -1.55% | 141.7K | $96,617 | 33 | Healthcare |
|
ACRV
Acrivon Therapeutics, Inc.
|
$2.00 | +1.01% | 6.5K | $85.60M | 32 | Healthcare |
|
ADIL
Adial Pharmaceuticals, Inc.
|
$4.35 | +5.58% | 60.0K | $11.42M | 32 | Healthcare |
|
APRE
Aprea Therapeutics, Inc.
|
$0.68 | -2.79% | 296K | $8.37M | 32 | Healthcare |
|
CING
Cingulate Inc.
|
$4.75 | -0.21% | 120.0K | $63.98M | 32 | Healthcare |
|
ELDN
Eledon Pharmaceuticals, Inc.
|
$2.50 | +0.40% | 718.5K | $192.97M | 32 | Healthcare |
|
GRI
GRI Bio, Inc.
|
$1.91 | -2.55% | 84.6K | $4.18M | 32 | Healthcare |
|
INAB
IN8bio, Inc.
|
$1.42 | +1.43% | 107.1K | $13.62M | 32 | Healthcare |
|
INMB
INmune Bio, Inc.
|
$1.94 | +0.52% | 266.8K | $51.58M | 32 | Healthcare |
|
MDGL
Madrigal Pharmaceuticals, Inc.
|
$493.62 | -1.16% | 246.4K | $11.40B | 32 | Healthcare |
|
MENS
Jyong Biotech Ltd.
|
$2.05 | +2.20% | 9.4K | $155.86M | 32 | Healthcare |
Showing 200 of 1,512 Biotechnology stocks
Biotechnology & Healthcare Stories
Evidence & Sources
- Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures.
- MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). It reads no news-sentiment or analyst data, and it is not a probability of future returns.
- Definitions follow standard investing terminology, with key terms explained inline in plain language where useful.
- Each price is the last quote we recorded, shown with the trading session it belongs to. Pages are served from a cache, so the copy you are reading can lag that quote. Each quote is a provider snapshot, not an exchange feed.
- This page is educational and does not constitute investment advice.
- All analysis is generated by AI models and should be verified with independent research.
Prices: 2026-10-06 trading session · Company analysis text: updated 2026-06-15